KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Invested Capital: 2010-2025

Historic Return on Invested Capital for Emergent BioSolutions (EBS) over the last 11 years, with Sep 2025 value amounting to 0.07%.

  • Emergent BioSolutions' Return on Invested Capital was N/A to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year change of. This contributed to the annual value of -0.06% for FY2022, which is 17.00% down from last year.
  • As of Q3 2025, Emergent BioSolutions' Return on Invested Capital stood at 0.07%, which was up 8.02% from 0.06% recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Return on Invested Capital ranged from a high of 0.17% in Q1 2021 and a low of -0.06% during Q4 2022.
  • For the 1-year period, Emergent BioSolutions' Return on Invested Capital averaged around 0.07%, with its median value being 0.07% (2025).
  • Its Return on Invested Capital has fluctuated over the past 5 years, first rose by 12bps in 2021, then fell by 17bps in 2022.
  • Over the past 3 years, Emergent BioSolutions' Return on Invested Capital (Quarterly) stood at 0.10% in 2021, then dropped by 17bps to -0.06% in 2022, then reached 0.07% in 2025.
  • Its Return on Invested Capital was 0.07% in Q3 2025, compared to 0.06% in Q2 2025 and -0.06% in Q4 2022.